Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A van Krimpen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|July 3, 1998
Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory moleculesM E Weijtens, R A Willemsen, B A van Krimpen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cellsR J van de Griend, B A van Krimpen, C P Ronteltap, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1984
Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodiesR J van de Griend, M J Giphart, B A Van Krimpen, et al.
Cellular Immunology|August 1, 1992
CD16 on human gamma delta T lymphocytes: expression, function, and specificity for mouse IgG isotypesE Braakman, J G van de Winkel, B A van Krimpen, et al.
International Immunology|July 1, 1991
Expression of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural killer cellsE Braakman, E Sturm, K Vijverberg, et al.
European Journal of Immunology|January 1, 1992
Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cellsE Braakman, V W Van Beusechem, B A Van Krimpen, et al.
Journal of Immunological Methods|February 10, 1984
Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cellsR J Van de Griend, B A Van Krimpen, S J Bol, et al.
Cancer Gene Therapy|November 12, 2005
Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancerC H J Lamers, R A Willemsen, P van Elzakker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytesP J Voogt, J H Falkenburg, W E Fibbe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1987
Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1R J van de Griend, W J Tax, B A van Krimpen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|July 3, 1998
Chimeric scFv/gamma receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory moleculesM E Weijtens, R A Willemsen, B A van Krimpen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cellsR J van de Griend, B A van Krimpen, C P Ronteltap, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1984
Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodiesR J van de Griend, M J Giphart, B A Van Krimpen, et al.
Cellular Immunology|August 1, 1992
CD16 on human gamma delta T lymphocytes: expression, function, and specificity for mouse IgG isotypesE Braakman, J G van de Winkel, B A van Krimpen, et al.
International Immunology|July 1, 1991
Expression of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural killer cellsE Braakman, E Sturm, K Vijverberg, et al.
European Journal of Immunology|January 1, 1992
Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cellsE Braakman, V W Van Beusechem, B A Van Krimpen, et al.
Journal of Immunological Methods|February 10, 1984
Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cellsR J Van de Griend, B A Van Krimpen, S J Bol, et al.
Cancer Gene Therapy|November 12, 2005
Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancerC H J Lamers, R A Willemsen, P van Elzakker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytesP J Voogt, J H Falkenburg, W E Fibbe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1987
Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1R J van de Griend, W J Tax, B A van Krimpen, et al.
Pageof 2